I'm sad to hear that about LLMs. I sometimes wonder if the software world is going to be "locked into" our existing languages, because it's what the LLMs can work with.
FWIW, I think the PRQL syntax is beautiful.
1,450 karma · joined March 28, 2018
I'm sad to hear that about LLMs. I sometimes wonder if the software world is going to be "locked into" our existing languages, because it's what the LLMs can work with.
FWIW, I think the PRQL syntax is beautiful.
It's not as elegant as PRQL, because of course it's bolted onto the existing SQL syntax, rather than a redesign from scratch. But it has a big name behind it, and it's actually running in prod in Google Cloud... so it might have more momentum.
[0]: https://cloud.google.com/blog/products/data-analytics/simpli...
But on the other hand, Russian aggression is back in the headlines these days...
> The problem is that 99% of teams don't need any of those knobs.
I keep hoping for a Docker Swarm revival. It's the right size for small-to-medium-size deployments with normal requirements.
Do you mean that Backstage has the metadata like what services call which other services, and AI needs that to make changes safely? Sounds helpful to both AI and human developers ;-)
I mean, presumably some future Democratic administration will reinstate the rule. But with this precedent set, this might become a switch that turns on and off every time the political winds change. When Republicans are in power, the US will do nothing at all to fight climate change. When Democrats are in power, they will belatedly try to undo the damage.
And of course there will be knock-on effects from other countries. Why should (for example) Mexico do anything at all to fight global warming, when the US (which is much richer, and a much larger polluter) declines to help?
This argument in favor of PaaS makes a lot of sense to me. A PaaS vendor might say, "sure, you could set up your own observability layer, configure storage for it, troubleshoot that one service that can't connect to the API's endpoint, etc. Or you could just check the "observability" box on our dashboard and boom, there it is."
I'm currently at a company that really likes setting everything up from scratch. And the amount of time my team has spent building out a platform, as opposed to providing business value, is really sobering.
In other words, if there's a record-high number of independents, how much of it is "market failure" where people want more options than the usual 2 parties?
They have a fascinating model -- they can buy the right to collect medical debts for pennies on the dollar. That debt would normally be bought by debt-collection companies. But once Undue Medical Debt buys a person's debt, they just... forgive it.
This means they can retire someone's $5,000 debt for a cost in the low hundreds. That might be life-changing for a poor family.
Now you're the institution
How's it feel to be the man?
It's no fun to be the man."
- Ben Folds, "The Ascent of Stan" https://www.youtube.com/watch?v=caCuRqedslY
===
ME: "OK, so, I have a question about the economics of medicine. Uh..." [pauses to gather thoughts to ask question]
GEMINI: "Sure! Medical economics is the field of..."
===
And it's aggravated by the fact that all the LLMs love to give you page-long responses before it's your turn to talk again!
Apprenticeships are still around in the modern day -- including for white-collar jobs! Kelly Vedi writes a lot about this in her Substack: https://kellyvedi.substack.com/
This is something I don't understand. These companies make good profits -- why don't they pay their experts well?
If you get the procedure and don't go back to an obesogenic diet, then it should be permanent.
The premise, IIUC, is that obesity is driven partly by mucosal overgrowth on the duodenum. This thicker-than-expected layer of mucus is less porous, which leads your digestive system to underestimate the number of calories you've consumed. Revita basically re-surfaces the duodenum.
So, the idea is that you get to a lower weight with the GLP-1 drugs, and then Revita can hopefully reset your set point there.
Their first clinical trial is still in progress, but I think it's interesting to watch.
"Links to Explain Oils in 2025": https://oils.pub/blog/2025/12/links.html
Especially if they amount they're going to be paid is going from $LOTS to zero.
So, yeah, it's "separate" spending in a sense, but it's not totally in its own sandbox.
I found the Concord Coalition [0], and their sister organization Concord Action [1].
I haven't done enough research to endorse them, but I'm just saying: they exist and this is their issue.
If those investors are satisfied with a return to a late-80s fiscal posture, then great. But if they're worried that spending would just creep up again once the pressure is off, they might "demand" further cuts.
This is a thing where having more parties would really help. If there were (say) 4 parties, each with ~25% of the seats, then they would have to bargain with each other and form coalitions, which I think would be a really healthy process for democracy.
If only we had some sort of federal Center in charge of Disease Control... ;-)
But I agree with you that the CDC was weirdly passive during COVID. You'd think it would have been their moment to shine.